Your session is about to expire
← Back to Search
Behavioral Intervention
Early Intervention Programs for Parenting Neglected Children
Phase 1 & 2
Waitlist Available
Led By Mary Dozier, Ph.D.
Research Sponsored by University of Delaware
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
* must have been in earlier randomized clinical trial
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up child age of 10 years
Awards & highlights
No Placebo-Only Group
Summary
This trial will compare the outcomes of two groups of neglecting parents, one of which received an intervention in infancy. It is expected that the intervention group will be more nurturing and follow their children's lead more, and that the children will have better outcomes in various areas than the control group.
Who is the study for?
This trial is for children who have been diagnosed with Conduct Disorder, ADHD, or Depression and were part of an earlier clinical trial. It focuses on the long-term effects of a parenting intervention given during infancy.
What is being tested?
The study tests if early childhood interventions like Developmental Education for Families and Attachment and Biobehavioral Catch-up can lead to better nurturing by parents and improved child outcomes in areas such as attachment, self-control, emotion management, and social interactions.
What are the potential side effects?
Since this trial involves educational and behavioral interventions rather than medications, traditional side effects are not expected. However, there may be emotional or psychological impacts from participating in the therapy sessions.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ child age of 10 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~child age of 10 years
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Attachment
Child aggression
Child diagnosis
+4 moreSecondary study objectives
Alpha and theta wave
Autonomic nervous system activity
Body mass index
+9 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Attachment and Biobehavioral Catch-upExperimental Treatment1 Intervention
Attachment and Biobehavioral Catch-up - 10 session intervention to enhance nurturance and following the lead
Group II: Developmental Education for FamiliesActive Control1 Intervention
Developmental Education for Families - 10 session intervention that targets cognitive development
Group III: Low-riskActive Control1 Intervention
Low-risk comparison group
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Attachment and Biobehavioral Catch-up
2002
Completed Phase 1
~440
Find a Location
Who is running the clinical trial?
University of DelawareLead Sponsor
161 Previous Clinical Trials
25,422 Total Patients Enrolled
1 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
220 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
Mary Dozier, Ph.D.Principal InvestigatorUniversity of Delaware
4 Previous Clinical Trials
760 Total Patients Enrolled
1 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
220 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Developmental Education for Families
- Group 2: Low-risk
- Group 3: Attachment and Biobehavioral Catch-up
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger